-- Sino Biopharmaceutical (HKG:1177) appointed Kang Xiaoyan as its chief medical officer, according to a Hong Kong bourse filing Tuesday.
Kang has over twenty five years of experience in clinical practice and drug research and development, Sino Biopharmaceutical said.
Michael Benjamin Tannenbaum, Director, Chief Executive Officer, on April 28, 2026, sold 184,194 shares in Figure Technology Solutions (FIGR) for $6,064,355. Following the Form 4 filing with the SEC, Tannenbaum has control over a total of 3,193,641 Class A common shares of the company, with 3,193,641 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/2064124/000149315226020776/xslF345X05/ownership.xml
Biswas Sanjit, 10% Owner, Director and Chief Executive Officer, on April 28, 2026, sold 263,900 shares in Samsara (IOT) for $7,671,995. Following the Form 4 filing with the SEC, Biswas Sanjit has control over a total of 1,554,913 common shares of the company, with 693,157 shares held directly and 861,756 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1642896/000189511126000007/xslF345X05/form4-04302026_110423.xml
Oil and gas company Star Energy (STAR.L) conditionally raised 8.5 million pounds sterling in gross proceeds through a share placing, and announced a retail offer.The retail offer is expected to raise gross proceeds of up to 600,000 pounds, with up to 4 million new shares being offered at 0.15 pound apiece. The results are due on May 7, according to a Friday filing.Zeus Capital is serving as Star Energy's nominated adviser, broker and bookrunner. VSA Capital is the agent for the placing.